HLA-DR2 and white matter lesion distribution in MS

Jorge Sepulcre, Joseph C. Masdeu, Ricardo Palacios, Joaquín Goñi, Beatriz Moreno, Mikel Tainta, Bartolomé Bejarano, Pablo Villoslada

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Human leukocyte antigen DR2 (HLA-DR2) is a well-established genetic risk factor for multiple sclerosis (MS). However, it is still unknown whether this factor is associated with a specific disease phenotype, and in particular, to a regional distribution of white matter (WM) lesion phenotype on magnetic resonance imaging (MRI). On a voxel-by-voxel basis, we analyzed the T1 and T2 MRI-derived lesion maps of 50 patients with MS in order to determine the possible influence of HLA-DR2 genotype on the lesional MRI pattern at early stages of the disease. HLA-DR2 was present in 15 (30%) patients of our cohort. They displayed similar WM lesion distribution as the subjects without this factor. Thus, lesion distribution in MS seems to be independent of the DR2 genotype.

Original languageEnglish (US)
Pages (from-to)328-331
Number of pages4
JournalJournal of Neuroimaging
Volume18
Issue number3
DOIs
StatePublished - Jul 1 2008

Keywords

  • HLA-DR2
  • Lesion distribution
  • MRI
  • Multilple sclerosis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology
  • Neuroscience(all)
  • Radiological and Ultrasound Technology

Fingerprint Dive into the research topics of 'HLA-DR2 and white matter lesion distribution in MS'. Together they form a unique fingerprint.

Cite this